We are live on ! Find out more
NERV icon

Minerva Neurosciences
NERV

67 hedge funds and large institutions have $170M invested in Minerva Neurosciences in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 19

0.7% more ownership

Funds ownership: 8.38% → 9.08% (+0.7%)

4% less funds holding

Funds holding: 70 → 67 (-3)

21% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 14

22% less capital invested

Capital invested by funds: $217M → $170M (-$46.7M)

Holders
67
Holders Change
-3
Holders Change %
-4.29%
% of All Funds
1.52%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
21
Reduced
19
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$1.67M
2
HCMT
Highland Capital Management (Texas)
Texas
+$1.38M
3
SFM
Sphera Funds Management
Israel
+$930K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$403K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$336K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$6.08M
2
NC
Nexthera Capital
New York
-$4.08M
3
JGC
J. Goldman & Co
New York
-$1.19M
4
NFA
Nationwide Fund Advisors
Ohio
-$950K
5
Renaissance Technologies
Renaissance Technologies
New York
-$858K
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$45.6M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$28.3M -$6.08M -122,631 -17%
HCMT
3
Highland Capital Management (Texas)
Texas
$13.1M +$1.38M +27,830 +11%
BlackRock
4
BlackRock
New York
$12.2M -$452K -9,117 -3%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$10.1M +$8.68K +175 +0.1%
Vanguard Group
6
Vanguard Group
Pennsylvania
$7.94M +$336K +6,784 +4%
Franklin Resources
7
Franklin Resources
California
$7.47M +$265K +5,337 +4%
IVAV
8
Index Venture Associates V
Jersey
$5.52M +$5.65M +113,980 New
AC
9
Ascend Capital
California
$4.96M +$233K +4,707 +5%
SFM
10
Sphera Funds Management
Israel
$4.69M +$930K +18,750 +24%
JP Morgan Chase
11
JP Morgan Chase
New York
$3.98M +$1.67M +33,641 +69%
CAM
12
Cormorant Asset Management
Massachusetts
$3.68M – – –
MWNA
13
Marshall Wace North America
New York
$2.87M -$62.2K -1,255 -2%
State Street
14
State Street
Massachusetts
$2.58M +$246K +4,957 +10%
Northern Trust
15
Northern Trust
Illinois
$1.99M -$185K -3,728 -8%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$1.63M +$1.39K +28 +0.1%
AG
17
Artal Group
Luxembourg
$1.52M – – –
Millennium Management
18
Millennium Management
New York
$1.19M -$321K -6,483 -21%
DCM
19
DAFNA Capital Management
California
$1.03M – – –
TCIM
20
TIAA CREF Investment Management
New York
$891K +$14.9K +301 +2%
BCM
21
Bridgeway Capital Management
Texas
$853K – – –
Bank of New York Mellon
22
Bank of New York Mellon
New York
$672K -$62K -1,250 -8%
Handelsbanken Fonder
23
Handelsbanken Fonder
Sweden
$575K – – –
Alyeska Investment Group
24
Alyeska Investment Group
Illinois
$496K – – –
Deutsche Bank
25
Deutsche Bank
Germany
$413K -$40.4K -815 -9%
1
2 3 4

NERV Hedge Fund Activity: Q4 2017 in Review

67 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q4 2017, worth a combined $170M — down 22% from $217M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of NERV and 11 opened new positions — a net loss of 3 holders — while 19 trimmed existing stakes and 21 added.

The largest buyer was JP Morgan Chase, adding an estimated $1.67M. The largest seller was Fidelity Investments, cutting an estimated $6.08M.

  • 67 institutional investors held Minerva Neurosciences (NERV) as of Q4 2017, down from 70 in Q3 2017.
  • Funds reported $170M of Minerva Neurosciences stock for Q4 2017, down 22% quarter-over-quarter.
  • 11 funds opened new Minerva Neurosciences positions in Q4 2017 and 14 closed out, a net change of -3 holders.
  • The largest Minerva Neurosciences buyer in Q4 2017 was JP Morgan Chase, an estimated $1.67M added.
  • The largest Minerva Neurosciences seller in Q4 2017 was Fidelity Investments, an estimated $6.08M sold.

Based on aggregated 13F filings for Q4 2017.